<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Interactive diabetes case 15: A 74-year-old patient with type 2 diabetes and recurrent hyperkalemia – B3</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Interactive diabetes case 15: A 74-year-old patient with type 2 diabetes and recurrent hyperkalemia – B3</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Interactive diabetes case 15: A 74-year-old patient with type 2 diabetes and recurrent hyperkalemia – B3</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lloyd Axelrod, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 22, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">ANSWER</span><span class="headingEndMark"> — </span>Correct.</p><p>At the emergency department, the repeat serum potassium level was 6.0 mEq/L, the serum creatinine was 1.7 mg/dL, and the blood glucose level was 321 mg/dL (17.8 mmol/L). An electrocardiogram showed nonspecific ST and T wave changes. The T waves were not peaked, and the QRS interval was not prolonged.</p><p>The patient received 10 units of <a class="drug drug_general" data-topicid="9030" href="/z/d/drug information/9030.html" rel="external">regular insulin</a> subcutaneously. The potassium level fell to 5.5 mEq/L one hour later and 5.0 mEq/L four hours later.</p><p>Review of the patient's medications revealed that the patient had been started on <a class="drug drug_general" data-topicid="9851" href="/z/d/drug information/9851.html" rel="external">ramipril</a> 10 mg daily and <a class="drug drug_general" data-topicid="8640" href="/z/d/drug information/8640.html" rel="external">irbesartan</a> 300 mg daily while in Italy. The angiotensin-converting enzyme (ACE) inhibitor (ramipril) and the angiotensin receptor blocker (ARB; irbesartan) were discontinued. The patient remains on <a class="drug drug_general" data-topicid="8529" href="/z/d/drug information/8529.html" rel="external">hydrochlorothiazide</a> 25 mg daily. In the hospital, the serum potassium level fluctuated between 5.0 and 5.5 mEq/L. One month later, the potassium was 5.4 mEq/L and the glycated hemoglobin (A1C) 8.6 percent.</p><p>At a subsequent office visit, fasting laboratory values are as follows: sodium 139 mEq/L, potassium 6.1 mEq/L, chloride 104 mg/dL, and bicarbonate 25 mEq/L; blood urea nitrogen (BUN) 55 mg/dL, creatinine 1.5 mg/dL, and glucose 217 mg/dL (12.1 mmol/L). The blood pressure is 140/90 mmHg supine and 145/95 mmHg upright. A repeat potassium the same day is 5.9 mEq/L with a glucose value of 181 mg/dL (10.1 mmol/L). The electrocardiogram is unchanged from the previous tracing. The patient and her family state that the patient has not resumed the <a class="drug drug_general" data-topicid="9851" href="/z/d/drug information/9851.html" rel="external">ramipril</a> or <a class="drug drug_general" data-topicid="8640" href="/z/d/drug information/8640.html" rel="external">irbesartan</a> and has not begun any new medications. She has been following the low potassium diet and counting carbohydrates with care, especially in view of the recent emergency hospitalization for hyperkalemia.</p><p>How would you manage the patient at this time?</p><p class="bulletIndent1"><span class="glyph">●</span>You review the patient's glucose diary. The glucose values are in the high 100s and low 200s before meals and at bedtime. You increase the doses of NPH insulin before breakfast and at bedtime to improve management of the diabetes and of the serum potassium level. (See  <a class="medical medical_answer" href="/z/d/html/4240.html" rel="external">"Interactive diabetes case 15: A 74-year-old patient with type 2 diabetes and recurrent hyperkalemia – C1"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>You review the patient's glucose diary. The glucose values are in the high 100s and low 200s before meals and at bedtime. You increase the doses of NPH insulin before breakfast and at bedtime to improve management of the diabetes and of the serum potassium level. You add <a class="drug drug_general" data-topicid="8455" href="/z/d/drug information/8455.html" rel="external">fludrocortisone</a> 0.1 mg daily by mouth as replacement therapy for aldosterone deficiency. (See  <a class="medical medical_answer" href="/z/d/html/4241.html" rel="external">"Interactive diabetes case 15: A 74-year-old patient with type 2 diabetes and recurrent hyperkalemia – C2"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>You review the patient's glucose diary. The glucose values are in the high 100s and low 200s before meals and at bedtime. You increase the doses of NPH insulin before breakfast and at bedtime to improve management of the diabetes and of the serum potassium level. You perform a cosyntropin stimulation test to rule out primary adrenal insufficiency and prescribe <a class="drug drug_general" data-topicid="9297" href="/z/d/drug information/9297.html" rel="external">cortisone acetate</a> 25 mg every morning and 12.5 mg every afternoon and <a class="drug drug_general" data-topicid="8455" href="/z/d/drug information/8455.html" rel="external">fludrocortisone</a> 0.1 mg daily, pending the results of the study. (See  <a class="medical medical_answer" href="/z/d/html/4242.html" rel="external">"Interactive diabetes case 15: A 74-year-old patient with type 2 diabetes and recurrent hyperkalemia – C3"</a>.)</p></div><div id="topicVersionRevision">Topic 4239 Version 8.0</div></div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
